Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...

Chronic Inflammation: Introduction

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...

Intracellular Signaling Affects Focal Adhesions

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...

Inflammatory Bowel Disease III: Crohn's Disease

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dehydration promotes intracellular lipid synthesis and accumulation.

Nature communications·2026

Same author

Discoidin Domain Receptor 1 Translocation to the Mitochondria Promotes Oxidative Stress and Apoptosis in Acute Kidney Injury.

Journal of the American Society of Nephrology : JASN·2026

Same author

The economic cost of outpatient primary care of adults with multimorbidity (HIV, diabetes, and hypertension) in rural South Africa.

Health policy and planning·2026

Same author

Kindlins regulate integrin- and growth factor-dependent ureteric bud formation.

Development (Cambridge, England)·2026

Same author

α-Parvin promotes glucose uptake and metabolism in skeletal muscle with minimal influence on hepatic insulin sensitivity.

Molecular metabolism·2026

Same author

α-Parvin regulation of cell re-arrangement is critical for ureteric bud branching morphogenesis.

bioRxiv : the preprint server for biology·2025

Search research articles

Related Experiment Video

Updated: May 20, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

How does TGF-β mediate tubulointerstitial fibrosis?

Leslie Gewin¹, Roy Zent

¹Department of Research, Veterans Affairs Hospital, Tennessee Valley Healthcare System, Nashville, TN, USA. leslie.gewin@vanderbilt.edu

Seminars in Nephrology

|July 28, 2012

Summary

Transforming growth factor-beta (TGF-β) drives tubulointerstitial fibrosis, a key factor in kidney disease progression. Understanding TGF-β

Area of Science:

Nephrology
Cell Biology
Molecular Biology

Background:

Tubulointerstitial fibrosis is a common pathway to end-stage renal disease across various kidney injuries.
Transforming growth factor-beta (TGF-β) is implicated in promoting fibrosis, but its precise mechanisms remain unclear due to its diverse cellular effects.
Understanding cell-specific TGF-β signaling is crucial for deciphering its role in fibrosis.

Purpose of the Study:

To review the mechanisms by which TGF-β signaling contributes to tubulointerstitial fibrosis.
To explore the differential roles of TGF-β in various renal cell types, including tubular epithelium and fibroblasts.
To identify future research directions for a better understanding of TGF-β-mediated tubulointerstitial fibrosis.

Main Methods:

More Related Videos

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

Related Experiment Videos

Last Updated: May 20, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

This study is a review of existing literature on TGF-β signaling in renal fibrosis.

It synthesizes findings on TGF-β's effects in different renal cell types.

It discusses the pleiotropic nature of TGF-β actions.

Main Results:

TGF-β signaling exhibits cell-type-dependent effects, influencing tubulointerstitial fibrosis progression.
Specific pathways in tubular epithelial cells and fibroblasts are highlighted as key contributors.
The complexity of TGF-β's role necessitates a nuanced, cell-specific approach.

Conclusions:

TGF-β plays a critical role in tubulointerstitial fibrosis, a major determinant of kidney disease outcome.
Further research into cell-specific TGF-β pathways is essential for developing targeted therapies.
Clarifying these mechanisms will improve the prediction and management of renal survival.